title: [Use of vitaflor to eradicate Helicobacter pylori in treatment of MALT-lymphoma of the stomach].
authors.forename: M L
authors.initials: ML
authors.lastname: Gershanovich
authors.forename: L N
authors.initials: LN
authors.lastname: Petrov
authors.forename: V P
authors.initials: VP
authors.lastname: Dobritsa
authors.forename: V P
authors.initials: VP
authors.lastname: Kalinovskiĭ
authors.forename: M V
authors.initials: MV
authors.lastname: Nikitina
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004338:Drug Combinations; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy* / Q000382:microbiology; D008875:Middle Aged; D012969:Sodium Fluoride / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D004338:Drug Combinations; C046732:vitafluor; D012969:Sodium Fluoride